Prosecution Insights
Last updated: October 04, 2026

Kolmar Korea Co. Ltd.

Technology area: Biotechnology & Pharmaceuticals

4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days

Analysis

Kolmar Korea Co. Ltd. manages a portfolio with 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are spread across 4 distinct examiners and 3 distinct art units. This distribution indicates a range of patent applications within the life sciences sector, as the company is engaging with 3 distinct art units at the USPTO. The variety of art units suggests that the company's research and development efforts span several different technical sub-fields.

The busiest examiner for the company is HOLT, ANDRIAE M, who is currently handling 1 busiest examiner pending office action. Because each of the 4 pending office actions is assigned to a different examiner, the workload is distributed across 4 distinct examiners. This lack of concentration suggests that the company's prosecution success is subject to the perspectives and timelines of several different examiners and art units. Practitioners must manage multiple distinct prosecution tracks simultaneously to maintain the momentum of the overall portfolio.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

4
Total Pending OAs
2
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
1
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (75%)
1
Medium (25%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (25%)
§103 only1 (25%)
Multi-statute (no §101)2 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
75% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
25% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HOLT, ANDRIAE M 1 49.3% +22.9%
CHEN, CATHERYNE 1 37.4% +18.0%
SCOTLAND, REBECCA LYNN 1 0.0% +0.0%
MAEWALL, SNIGDHA 1 58.8% +10.5%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18552426 MULTILAYER EMULSION COSMETIC COMPOSITION SCOTLAND, REBECCA LYNN 5d
18931272 SULFATE-BASED SURFACTANT FREE ORAL CARE COMPOSITION WITH IMPROVED LOW TEMPERATURE STABILITY HOLT, ANDRIAE M —
18572618 ANTIBACTERIAL COMPOSITION CHEN, CATHERYNE —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18931272 SULFATE-BASED SURFACTANT FREE ORAL CARE COMPOSITION WITH IMPROVED LOW TEMPERATURE STABILITY HOLT, ANDRIAE M —
18572618 ANTIBACTERIAL COMPOSITION CHEN, CATHERYNE —
17639011 DISPERSION OF CERIUM OXIDE FOR ENHANCING SKIN BARRIER, SKIN MOISTURIZING, AND/OR BLOCKING FINE DUST, AND COSMETIC COMPOSITION COMPRISING SAME MAEWALL, SNIGDHA —

Top Art Units

Art UnitApps
1655 1
1615 1
1612 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18931272 SULFATE-BASED SURFACTANT FREE ORAL CARE COMPOSITION WITH IMPROVED LOW TEMPERATURE STABILITY HOLT, ANDRIAE M — §102§103 Non-Final OA — Pending Oct 30, 2024
18572618 ANTIBACTERIAL COMPOSITION CHEN, CATHERYNE 1655 §101§103§112 Final Rejection — Pending Dec 20, 2023
18552426 MULTILAYER EMULSION COSMETIC COMPOSITION SCOTLAND, REBECCA LYNN 1615 §103§112 Non-Final OA 5d Pending Sep 25, 2023
17639011 DISPERSION OF CERIUM OXIDE FOR ENHANCING SKIN BARRIER, SKIN MOISTURIZING, AND/OR BLOCKING FINE DUST, AND COSMETIC COMPOSITION COMPRISING SAME MAEWALL, SNIGDHA 1612 §103 Final Rejection — Pending Feb 28, 2022

Managing Kolmar Korea Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month